Benefits of a patient-assisted medication adherence program for long-acting injectable risperidone on high-cost outcomes in schizophrenia
Abstract
Authors
B Astruc J.J. Jalbert F. Rouillon M. Rossignol F. Baylé B. David R. Bennoune B. Avouac L. Abenhaim L. Grimaldi-Bensouda